Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 7, 2019; 25(33): 4999-5016
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4999
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4999
Article | Type of article | Age group | Country | Patient source | n (exp/control) | Inclusion criteria | Exclusion criteria | LGG (dosage) | Control group | Duration of intervention | Etiology |
Basu et al[25], 2007 | RCT; 1 center; Duration: 1 yr | Children | India | Inpatients | 323/323 | ≥ 3 watery stools/day without visible blood or mucus; <10 white blood cells/high-power field and no red cells, mucus flakes, or bacteria on stool microscopy; negative hanging drop preparation; negative bacterial stool culture | Systemic illness other than diarrhea on admission; systemic complications of diarrhea during hospitalization; failure to provide informed consent | 120 × 106 ; CFU/day | ORF | 7 d | Bacterial diarrhea excluded; Rotavirus-induced diarrhea 75.8% |
Basu et al[24], 2009a | RCT; 1 center Duration: 1 yr | Children | India | Inpatients | 188/185 | ≥ 3 watery stools/day without macroscopic blood or mucus, <10 white blood cells/high-power field, and no red blood cells, mucus flakes, or bacteria on stool microscopy; negative hanging drop preparation; negative bacterial stool culture | Symptoms of illness other than diarrhea; development of any systemic complication of diarrhea during hospitalization; failure to provide informed consent | 2 × 1010 CFU/day | ORF | 7 d or until diarrhea stopped | Bacterial diarrhea excluded; Rotavirus diarrhea 57.1% |
Basu et al[24] 2009b | RCT; 1 center Duration: 1 yr | Children | India | Inpatients | 186/185 | ≥ 3 watery stools/day without macroscopic blood or mucus, <10 white blood cells/high-power field, and no red blood cells, mucus flakes, or bacteria on stool microscopy; negative hanging drop preparation; negative bacterial stool culture | Symptoms of illness other than diarrhea; development of any systemic complication of diarrhea during hospitalization; failure to provide informed consent | 2 × 1012 CFU/day | ORF | 7 d or until diarrhea stopped | Bacterial diarrhea excluded; Rotavirus-induced diarrhea 56.06% |
Canani et al[26], 2007 | RCT; 6 centers Duration: 12 mo | 3-36 mo | Italy | Outpatients | 100/92 | > 2 loose or liquid stools/day for <48 h | Malnutrition; severe dehydration; coexisting acute systemic illness; immunodeficiency; underlying severe chronic disease; cystic fibrosis; food allergy or other chronic GI diseases; use of probiotics in the previous 3 wk; antibiotics or any other antidiarrheal medication in the previous 3 wk; poor compliance | 12 × 109 CFU/day | No details given | 5 d | Stool culture in only a few participants and no data presented |
Costa et al[27] 2003 | RCT; 1 center | Boys, 1-24 mo | Brazil | Inpatients | 61/63 | Acute diarrhea (3 or more watery or loose stools per 24 h during at least one 24-h period in the 72 h before admission) with moderate or severe dehydration after correction with rapid IV fluids | Systemic infections requiring antibiotics; severe malnutrition (weight for age < 65% of NCHS standards; bloody diarrhea | 1010 CFU/day | Inulin 320 mg/day | Unclear | Rotavirus-induced diarrhea 50%; Bloody diarrhea excluded |
Czerwionka-Szaflarska et al[28], 2009 | RCT; 1 center | Unclear | Poland | Inpatients | 50/50 | Infants and children with acute infectious diarrhea and failed oral rehydration | Bloody stools; coexisting disease that may influence the course of diarrhea | 50 ml/kg/day | Unclear | Unclear | Bloody diarrhea excluded; Rotavirus-induced diarrhea 58% |
Schnadower et al[8] 2018 | RCT | 3-48 mo | United States | University-affiliated PED | 483/488 | ≥ 3 watery stools per day, with or without vomiting, for fewer than 7 d | Pancreatitis, bilious emesis, or hematochezia; a known allergy to L. rhamnosus GG or to microcrystalline cellulose or a known allergy to erythromycin, clindamycin, and beta-lactam antibiotic agents; caregiver did not speak English or Spanish; children receiving antibiotics | 1 × 1010 CFU twice daily | Matching placebo | 5 d | Norovirus GI or GII 19.6%; Rotavirus 17.7%; Adenovirus 9.1%; Clostridium difficile 7.4%; Shigella 5.0% |
Guandalini et al[29], 2000 | RCT; multicenter Duration: 1 yr | 1-36 mo | Listed as follows | Inpatients and outpatients | 147/140 | Infants and children with > 4 liquid or semiliquid stools/day for 1 to 5 d | Previous probiotic usage; untreated underlying chronic small bowel disease; inflammatory bowel disease; any underlying chronic disease or immunosuppressive disease or treatment | ≥10 × 109 CFU/250 mL/day with ORF | ORF | As tolerated for 4-6 h, then ad libitum | Rotavirus 35%; Bacteria 24%; Parasites 4.5%; No pathogens 34.5%; Bloody diarrhea 8.7% |
Guarino et al[30], 1997 | RCT; 1 center Duration: 3 mo | 3-36 mo | Italy | Outpatients | 52/48 | Infants and children with ≥ 3 watery stools/day for < 48 h | Antibiotic treatment in the last 3 wk, breastfeeding; a weight: height ratio < the 5th percentile | 6 × 109 CFU/day with ORF | ORF | ≤5 d | Rotavirus-induced diarrhea 61% |
Isolauri et al[31], 1994 | RCT; 1 center Duration: not stated | ≤ 36 mo | Finland | Inpatients | 21/21 | Infants and children with > 3 watery stools/day for < 7 d and stools positive for rotavirus; average dehydration of approximately 5% in both groups | Not stated | 2 × 1010 CFU/day | No probiotic | 5 d | Rotavirus-induced diarrhea 100% |
Jasinski et al[32], 2002 | RCT; 12 centers Duration: not stated | 1-36 mo | Africa Egypt Europe America | Inpatients and outpatients | 45⁄52 | > 3 watery stools in 12 h or 1 liquid or semiliquid stool with mucus, pus, or blood; < 5 d | Antibiotic or probiotic use in the last 5 d; chronic diseases of the small or large intestine; immunosuppression; phenylketonuria | ORS + LGG 1010 CFU⁄ day | ORS with no LGG | Unclear | Bacterial pathogens 68%; Rotavirus 40.0%; parasites 6%; No pathogens identified: probiotic group 25% |
Misra et al[33], 2009 | RCT; 1 center Duration: not stated | ≤ 36 mo | India | Inpatients | 105/ 105 | > 3 stools per day (watery or assuming the shape of the container) | Parents refused consent; children living outside the municipal area; bloody diarrhea; severe dehydration; shock, inability to take and retain oral foods; suspected systemic infection | 1 × 106-9 CFU/day | Crystalline micro cellulose | Unclear | Rotavirus 25.6%; Bloody diarrhea excluded; White blood cells in stools 14.3%; Bacterial diarrhea 4.7% |
Nixon et al[34], 2012 | RCT | 6-72 mo | United States | PED | 77/78 | More than 2 loose stools in the last 24 h | Risk factors for non-viral diarrhea (prolonged diarrhea lasting more than 7 d, gross blood, antibiotic exposure, or inflammatory bowel disease); immune compromise; risk factors for probiotic-associated systemic illness or an allergy to milk products | LGG powder twice daily | Inulin | 5 d | Unclear |
Pant et al[35], 1996 | RCT; 1 center Duration: 6 wk | 1-24 mo | Thailand | Inpatients | 20/19 | Infants and children with > 3 watery stools in last 24 h and diarrhea for < 14 d | Exclusive breastfeeding; septicemia | 109-10 CFU twice daily | Placebo | 2 d | Bloody stools 33.3%; Rotavirus 17.9%; Astrovirus 2.5% |
Raza et al[36], 1995 | RCT; 1 center Duration: 2 mo | 1-24 mo | Pakistan | Inpatients | 21/19 | Undernourished infants and children with > 3 watery stools in the last 24 h for < 14 d and at least moderate dehydration | Severe malnutrition; septicemia | 2 × 1011-12 CFU/day | Placebo | 2 d | Bloody diarrhea |
Ritchie et al[37], 2010 | RCT; 1 center Duration: 21 mo | 4-24 mo | Australia | Unclear | 33/31 | Aboriginal children with acute diarrhea defined as ≥ 3 loose stools during 24 h before presentation for < 7 d and able to tolerate ORF | Oxygen required during the study period; chronic cardiac, renal, or respiratory disease; previous gastrointestinal surgery; proven sucrose intolerance; suspected on known immunodeficiency; probiotic use before enrollment; younger than 4 mo of age | > 15 × 109 CFU/day | Identical placebo | 3 d | Bacterial pathogens 12.5%; Rotavirus 8.5%; Parasites 6% |
Shornikova et al[38], 1997 | RCT; 1 center Duration: 1 yr | 1-36 mo | Russia | Inpatients | 59/64 | ≥ 1 watery stool in the last 24 h and diarrhea for < 5 d | Not stated | 1010 CFU/day | Placebo | 5 d | Rotavirus 27.4%; Bacterial diarrhea 21% |
Sindhu et al[39], 2014 | RCT | 6-60 mo | India | Unclear | 65/59 | Diarrhea was defined as ≥ 3 loose watery stools within a 24-h period | Coinfections (the presence of both rotavirus and Cryptosporidium); severe malnutrition; probiotic consumption in the preceding month; allergy to probiotics; acute abdomen or colitis | 1010 CFU and 170 mg of microcrystalline /day cellulose | 170 mg of cellulose | 4 wk | Rotavirus 52.4%; Cryptosporidium species 47.6% |
Sunny et al[40] 2014 | Open-label RCT | 6-60 mo | India | OPD or PED | 100/100 | Passage of three or more loose stools in the last 24 h | Severe malnutrition; dysentery; clinical evidence of coexisting acute systemic illnesses; clinical evidence of chronic disease; probiotic use in the preceding three weeks; antibiotic use | 1 × 1010 CFU per day | ORS and zinc 20 mg/d | 5 d | Rotavirus 24.1% |
- Citation: Li YT, Xu H, Ye JZ, Wu WR, Shi D, Fang DQ, Liu Y, Li LJ. Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis. World J Gastroenterol 2019; 25(33): 4999-5016
- URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4999.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i33.4999